COOPERATIVE STUDY OF CHILDREN'S CANCER
儿童癌症的合作研究
基本信息
- 批准号:3556226
- 负责人:
- 金额:$ 15.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1976
- 资助国家:美国
- 起止时间:1976-12-01 至 1988-11-30
- 项目状态:已结题
- 来源:
- 关键词:6 thioguanine 6 thiopurine Ewing's tumor Mycobacterium bovis asparaginase central nervous system child (0-11) combination cancer therapy cooperative study cyclophosphamide cytosine arabinoside daunorubicin doxorubicin drug adverse effect human subject human therapy evaluation immunosuppression lymphocytic leukemia lymphosarcoma medical education methotrexate myelogenous leukemia neoplasm /cancer chemotherapy neoplasm /cancer diagnosis neoplasm /cancer education neoplasm /cancer immunotherapy nephroblastoma neuroblastoma pediatric neoplasm /cancer postoperative state prednisone rhabdomyosarcoma vincristine
项目摘要
This proposal describes the multimodal program to be employed by the Indiana
University Pediatric Oncology Staff as an active participant in the Children's
Cancer Study Group (CCSG). The program will be implemented by a) registering
and enrolling all available patients onto CCSG protocol studies; b) carefully
attending to the quality control of every aspect of the protocol; c) maintaining
communication between the members of the multimodal team to ensure that all are
kept informed about the management of each study patient as well as the results
of current CCSG protocols; d) fostering an environment of scientific excellence;
e) contributing ideas to and serving on study committees for CCSG. This program
should result in the optimum treatment for children with cancer and at the same
time provide a data base for the development of better treatment modalities for
the future.
本提案描述了印第安纳州将采用的多式联运方案
大学儿科肿瘤学工作人员积极参与儿童
癌症研究小组(CCSG)。 该计划将通过a)注册
并将所有可用患者纳入CCSG方案研究; B)仔细
参与方案各方面的质量控制; c)维护
多式联运团队成员之间的沟通,以确保所有人都
随时了解每例研究患者的管理以及结果
(d)促进科学卓越的环境;
e)为CCSG的研究委员会提供意见和服务。 这个程序
应该为癌症儿童提供最佳治疗,
时间为开发更好的治疗模式提供了数据基础,
未来
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT L BAEHNER其他文献
ROBERT L BAEHNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT L BAEHNER', 18)}}的其他基金
LEUKOCYTE METABOLISM RELATED TO RECURRENT INFECTION
与反复感染相关的白细胞代谢
- 批准号:
3135876 - 财政年份:1986
- 资助金额:
$ 15.87万 - 项目类别:
LEUKOCYTE METABOLISM RELATED TO RECURRENT INFECTION
与反复感染相关的白细胞代谢
- 批准号:
3135875 - 财政年份:1986
- 资助金额:
$ 15.87万 - 项目类别:
相似海外基金
Tyrosine kinase inhibitor / 6-thiopurine drug interactions via nucleobase transporters
酪氨酸激酶抑制剂/6-硫嘌呤药物通过核碱基转运蛋白的相互作用
- 批准号:
540955-2019 - 财政年份:2019
- 资助金额:
$ 15.87万 - 项目类别:
University Undergraduate Student Research Awards














{{item.name}}会员




